http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665200/
This article has been cited by other articles in PMC.
Abstract
We
describe here three patients with the Alzheimer's Disease (AD) whose
behavioral symptoms were improved remarkably as a result of the turmeric
treatment, which is the traditional Indian medicine. Their cognitive
decline and Behavioral and Psychological Symptoms of Dementia (BPSD)
were very severe. All three patients exhibited irritability, agitation,
anxiety, and apathy, two patients suffer from urinary incontinence and
wonderings. They were prescribed turmeric powder capsules and started
recovering from these symptoms without any adverse reaction in the
clinical symptom and laboratory data. After 12 weeks of the treatment,
total score of the Neuro-Psychiatric Inventory-brief questionnaire
decreased significantly in both acuity of symptoms and burden of
caregivers. In one case, the Mini-Mental State Examination (MMSE) score
was up five points, from 12/30 to 17/30. In the other two cases, no
significant change was seen in the MMSE; however, they came to recognize
their family within 1 year treatment. All cases have been taking
turmeric for more than 1 year, re-exacerbation of BPSD was not seen. The
present cases suggest a significant improvement of the behavioral
symptoms in the AD with the turmeric treatment, leading to probable
benefit of the use of turmeric in individuals with the AD with BPSD.
Keywords: Alzheimer's
disease, behavioral and psychological symptoms of dementia, curcumin,
mini-mental state examination, neuropsychiatric inventory-brief
questionnaire, turmeric
Introduction
Alzheimer's
disease (AD) is the most common form of dementia and it is
characterized by the progressive cognitive impairment. The behavioral
and psychological symptoms of the dementia (BPSD) are also commonly seen
in patients with AD, such as hallucinations, delusions, apathy,
depression, agitation, irritability, and wandering. These symptoms can
have serious harmful effects on patients’ Quality of Life (QOL) and are
also a burden to caregivers and increasing the costs of care.[1]
Therefore, the treatment of BPSD is as important as that of core
symptom such as memory disturbance and disorientation.
Acetylcholinesterase (AChE) inhibitors and N-Methyl-d-Aspartate (NMDA)
receptor uncompetitive antagonist (memantin hydrochloride) are commonly
used for the treatment of AD. They are effective in core symptoms and
BPSD treatment;[2–4]
however, the effects are not completely satisfactory. They can cause
adverse effects such as nausea, extra-pyramidal symptoms, drowsiness,
and the other symptoms.
Neuropathologically,
AD is characterized by the presence of senile plaques, neurofibrillary
tangles, persistent neuronal loss, although, the neurotoxic mechanisms
have not been completely elucidated. It is clear that both oxidative
stress and inflammation play a key role in the illness. Recent reports
have suggested therapeutic potential of curcumin in the pathophysiology
of AD, because of its antioxidant, anti-inflammatory, and anti-amyloid
effects.[5–11] Curcumin is a polyphenolic molecule extracted from turmeric, the spice consisting of the powdered rhizome of the plant Curcuma longa
Linn. Turmeric contains about 5% curcumin, which gives the spice its
yellow color and is used widely as yellow food coloring. It has also a
medical history that date back 5000 years. It has been extensively used
to treat various ailments for centuries in Ayurveda, the traditional
Indian system of medicine, such as arthritis, gastric ulcer, jaundice,
fever, liver disease, urinary tract disease, skin disease, and as a
“blood purifier.”[12]
Many pharmacological studies have been conducted to describe the
multiple biological actions of curcumin. Curcumin has also demonstrated
neuroprotective effects in animal models of not only AD;[13] however, also Parkinson's disease,[14–16] depression,[17–19] epilepsy,[20]
and so on. Epidemiological studies in India, a country where turmeric
consumption is widespread, suggest that it has one of the lowest
prevalence rates of AD in the world.[21,22]
In spite of the high efficacy and safety, curcumin has not yet been
approved as a therapeutic agent. Here, we present three cases with the
AD whose behavioral symptoms and ability perform Activities of Daily
Living (ADL) were improved by turmeric treatment without any adverse
effects.
Case reports at the link.
No comments:
Post a Comment